Hereditary Spastic Paraplegia Clinical Trial
Official title:
Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders
The aim of this study is to determine the clinical spectrum and natural progression of Hereditary Spastic Paraplegias (HSP) and related disorders in a prospective multicenter natural history study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the genetic etiology and molecular mechanisms of these diseases.
The investigators will perform a registry-based standardized prospective Natural History Study (NHS) in HSPs and related disorders. Participants will be seen annually. At study visits a standardized clinical examination will be performed including application of clinical rating scales (selection of rating scales may vary depending on the individual phenotype and specific genotype); data will be entered into a clinical database (HSP Registry; https://www.hsp-registry.net). At all study visits, patients will be asked to donate biosamples; biomaterial collection is optional and participants can elect to participate in sampling of blood, urine, CSF, and/or a skin biopsy. Optionally, additional examinations may be performed including imaging, quantitative movement analysis, neuropsychological examinations, analysis of patient or observer reported outcomes and OMICS analysis to characterize molecular biomarkers. In participants without a genetic diagnosis, next generation sequencing may be performed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06117020 -
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
|
Phase 1 | |
| Completed |
NCT05373082 -
Identification of Modifying Factors in Hereditary Spastic Paraplegia
|
||
| Terminated |
NCT02859428 -
Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31
|
||
| Completed |
NCT03104088 -
Studying Cognition in SPG4
|
||
| Recruiting |
NCT05848271 -
Natural History Study of Patients With HPDL Mutations
|
||
| Completed |
NCT02604186 -
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia
|
Phase 2/Phase 3 | |
| Completed |
NCT04912609 -
Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)
|
||
| Recruiting |
NCT03206190 -
The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4
|
N/A | |
| Completed |
NCT03627416 -
Repetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy
|
N/A | |
| Recruiting |
NCT04875416 -
Phenotype, Genotype and Biomarkers 2
|
||
| Withdrawn |
NCT05411627 -
A Pilot Study of Shockwave Therapy in HSP
|
N/A | |
| Completed |
NCT03961906 -
Physiotherapy in Hereditary Spastic Paraplegia
|
Phase 2 | |
| Completed |
NCT05767268 -
Assessment of the Psychophysical State During Rehabilitation Treatment With Lokomat
|
||
| Completed |
NCT02852278 -
A Patient Centric Motor Neuron Disease Activities of Daily Living Scale
|
||
| Completed |
NCT04180098 -
Improving Gait Adaptability in Hereditary Spastic Paraplegia
|
N/A | |
| Completed |
NCT05613114 -
Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia
|
N/A | |
| Completed |
NCT00023075 -
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
|
N/A | |
| Recruiting |
NCT04712812 -
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
|
||
| Recruiting |
NCT05354622 -
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
|
||
| Enrolling by invitation |
NCT02327845 -
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
|